New Treatments for Bipolar

In this early evening webinar we will be bringing the latest research on Bipolar to the fore.

You'll hear talks from leading experts in clinical, research and lived experience-led approaches working in the field, and have the opportunity to ask questions in the Q&A.

We will then share the progress of ASCEnD, a groundbreaking study currently recruiting, which is looking at the clinical and cost-effectiveness of the combination of the antipsychotic aripiprazole and antidepressant called sertraline, in comparison with quetiapine, for the treatment of bipolar depression.